Last week, the US Food and Drug Administration (FDA) approved the world's first vaccine against the chikungunya virus – Ixchiq. The vaccine candidate has been designed and manufactured at the University of Tartu. The human clinical trials were conducted by the biotechnology company Valneva Austria GmbH.
On November 20 at 2.15 Kaspar Reier will defend his Doctoral Thesis on Molecular Biology „Quantity, stability and disparity of ribosomal components in Escherichia coli stationary phase“.
The project BeeYeast brought the grand prize at the iGEM (International Genetically Engineered Machine) competition, the world championship in synthetic biology.
On November 10 at 09:15 Mariann Koel will defend her doctoral thesis “The molecular interactions between trophoblast and endometrial cells in embryo implantation” on Cell Biology.
In order to support just transition in Ida-Viru County, a consortium of 22 research groups has been established in cooperation between Tallinn University of Technology and the University of Tartu.
On 17 November at 12:00, Marit Karelson will defend her doctoral thesis „Le Temps d’engagement dans les œuvres d’André Gide et de Johannes Semper: les univers fictionnels entre l’élan vital et la littérature engagée“
The Estonian solar car team Solaride won third place in the Bridgestone World Solar Challenge in Australia at the end of October and got a special award for best performance in technical inspection.
On 16 October, the first cooperation seminar of Tallinn University of Technology and the University of Tartu’s consortium of the Just Transition Fund was held at the Virumaa College of the Tallinn University of Technology. The event brought together 22 research teams whose work will help develop technologies and monitor societal transition in the Ida-Viru region over the next six years.
The third ENLIGHT Teaching and Learning Conference took place at the University of Bordeaux from 11 to 13 October 2023. The focus of the conference was on empowering students.